Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion

Por Guyennon, Aurélie, Mihaila, Marius, Palma, John, Lombard-Bohas, Catherine, Chayvialle, Jean-Alain, Pilleul, Frank
Publicado em 2010

Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers

Por Freis, Patricia, Graillot, Emmanuelle, Rousset, Pascal, Hervieu, Valérie, Chardon, Laurence, Lombard-Bohas, Catherine, Walter, Thomas
Publicado no Sci Rep (2017)

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review

Por Michael, Michael, Garcia‐Carbonero, Rocio, Weber, Matthias M., Lombard‐Bohas, Catherine, Toumpanakis, Christos, Hicks, Rodney J.
Publicado no Oncologist (2017)

Molecular and Clinical Differences between Adenocarcinomas of the Esophagus and of the Gastric Cardia

Por Tanière, Philippe, Martel-Planche, Ghislaine, Maurici, Daniela, Lombard-Bohas, Catherine, Scoazec, Jean-Yves, Montesano, Ruggero, Berger, Françoise, Hainaut, Pierre
Publicado em 2001

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma

Por Couronne, Thomas, Girot, Paul, Hadoux, Julien, Lecomte, Thierry, Durand, Alice, Fine, Caroline, Vandevoorde, Katia, Lombard-Bohas, Catherine, Walter, Thomas
Publicado no Endocr Connect (2020)

Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-3 Trial

Por Lombard-Bohas, Catherine, Yao, James C., Hobday, Timothy, Van Cutsem, Eric, Wolin, Edward M., Panneerselvam, Ashok, Stergiopoulos, Sotirios, Shah, Manisha H., Capdevila, Jaume, Pommier, Rodney
Publicado no Pancreas (2015)

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Por de Mestier, Louis, Walter, Thomas, Evrard, Camille, de Boissieu, Paul, Hentic, Olivia, Cros, Jérôme, Tougeron, David, Lombard-Bohas, Catherine, Rebours, Vinciane, Hammel, Pascal, Ruszniewski, Philippe
Publicado no Neuroendocrinology (2020)

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with...

Por Lamarca, Angela, Barriuso, Jorge, Kulke, Matthew, Borbath, Ivan, Lenz, Heinz-Josef, Raoul, Jean Luc, Meropol, Neal J, Lombard-Bohas, Catherine, Posey, James, Faivre, Sandrine, Raymond, Eric, Valle, Juan W
Publicado no Br J Cancer (2018)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

Por Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
Publicado no Gastrointest Cancer Res (2014)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study

Por Yao, James C., Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Voi, Maurizio, Brandt, Ulrike, He, Wei, Chen, David, Capdevila, Jaume, de Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Pommier, Rodney, Öberg, Kjell
Publicado no J Clin Oncol (2016)

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors

Por Salazar, Ramon, Garcia‐Carbonero, Rocio, Libutti, Steven K., Hendifar, Andrew E., Custodio, Ana, Guimbaud, Rosine, Lombard‐Bohas, Catherine, Ricci, Sergio, Klümpen, Heinz‐Josef, Capdevila, Jaume, Reed, Nicholas, Walenkamp, Annemiek, Grande, Enrique, Safina, Sufiya, Meyer, Tim, Kong, Oliver, Salomon, Herve, Tavorath, Ranjana, Yao, James C.
Publicado no Oncologist (2017)

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma

Por Niogret, Julie, Limagne, Emeric, Thibaudin, Marion, Blanc, Julie, Bertaut, Aurelie, Le Malicot, Karine, Rinaldi, Yves, Caroli-Bosc, François-Xavier, Audemar, Franck, Nguyen, Suzanne, Sarda, Corinne, Lombard-Bohas, Catherine, Locher, Christophe, Carreiro, Miguel, Legoux, Jean-Louis, Etienne, Pierre-Luc, Baconnier, Mathieu, Porneuf, Marc, Aparicio, Thomas, Ghiringhelli, Francois
Publicado no Cancers (Basel) (2020)

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

Por Yao, James C., Lombard-Bohas, Catherine, Baudin, Eric, Kvols, Larry K., Rougier, Philippe, Ruszniewski, Philippe, Hoosen, Sakina, St. Peter, Jessica, Haas, Tomas, Lebwohl, David, Van Cutsem, Eric, Kulke, Matthew H., Hobday, Timothy J., O'Dorisio, Thomas M., Shah, Manisha H., Cadiot, Guillaume, Luppi, Gabriele, Posey, James A., Wiedenmann, Bertram
Publicado no J Clin Oncol (2010)